Chad F. Babcock

Family Medicine
5926 W Northwest Hwy
One Medical W Bswh
Dallas, TX 75225

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1 publications

A Phase II Open-Label Study of Bermekimab in Patients with Hidradenitis Suppurativa Shows Resolution of Inflammatory Lesions and Pain.

A Phase II Open-Label Study of Bermekimab in Patients with Hidradenitis Suppurativa Shows Resolution of Inflammatory Lesions and Pain.

Journal: The Journal of investigative dermatology
Published: May 09, 2019
Showing 1-1 of 1

Last Updated: 09/26/2026